Understanding how genes control the function of insulin-producing cells in diabetes
Genetic control of mature beta cell function and identity
This study is looking at how our genes affect the important cells that help control blood sugar, especially when they stop working properly in diabetes, and it hopes to find new ways to help these cells regain their healthy function for better treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10991383 on NIH RePORTER |
What this research studies
This research investigates the genetic factors that regulate the function and identity of beta cells, which are crucial for maintaining blood sugar levels. It aims to understand how these cells can lose their mature function and become dysfunctional, a process known as de-differentiation, particularly in the context of diabetes. By mapping genetic networks and testing their effects on beta cell behavior in both human and mouse models, the research seeks to identify potential targets for restoring healthy beta cell function. Patients may benefit from insights that could lead to new treatments for diabetes by reversing the loss of beta cell function.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults with type 1 or type 2 diabetes who are experiencing issues with blood glucose regulation.
Not a fit: Patients with diabetes who have already lost all beta cell function or those with other unrelated metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that restore the function of insulin-producing cells in diabetes patients.
How similar studies have performed: Other research has shown promise in targeting genetic pathways to restore beta cell function, indicating that this approach may lead to significant advancements in diabetes treatment.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Blum, Barak — University of Wisconsin-Madison
- Study coordinator: Blum, Barak
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.